Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Acronym
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Not Specified
Patient information sheet
Condition
Hypertension
Intervention
Timolol 10 mg twice daily or placebo for 14 days
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/03/1996
Overall trial end date
30/09/1996
Reason abandoned
Eligibility
Participant inclusion criteria
Healthy males
Participant type
Patient
Age group
Adult
Gender
Male
Target number of participants
Added as of 23/05/2008: 6
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/03/1996
Recruitment end date
30/09/1996
Locations
Countries of recruitment
United Kingdom
Trial participating centre
University of Cambridge
Cambridge
CB2 2QQ
United Kingdom
Sponsor information
Organisation
NHS R&D Regional Programme Register - Department of Health (UK)
Sponsor details
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk
Sponsor type
Government
Website
Funders
Funder type
Government
Funder name
NHS Executive Eastern (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
1997 results in http://www.ncbi.nlm.nih.gov/pubmed/9088585
Publication citations
-
Results
Ferro A, Hall JA, Dickerson JE, Brown MJ, A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects., Br J Clin Pharmacol, 1997, 43, 3, 301-308.